lorazepam has been researched along with 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bueno, OF; Galduróz, JC; Lucchesi, LM; Manzano, GM; Pompéia, S; Tufik, S | 1 |
1 trial(s) available for lorazepam and 1,1-dimethylheptyl-11-hydroxytetrahydrocannabinol
| Article | Year |
|---|---|
A double-dissociation of behavioural and event-related potential effects of two benzodiazepines with similar potencies.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Anxiety Agents; Double-Blind Method; Dronabinol; Evoked Potentials; Evoked Potentials, Auditory; Female; Flunitrazepam; Humans; Lorazepam; Male; Memory, Short-Term; Perception; Photic Stimulation; Placebos; Psychomotor Performance; Reaction Time; Reference Values | 2000 |